These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22524110)

  • 1. [Antimicrobial peptides: a potential arsenal against HIV infection].
    Castañeda-Delgado JE; Cervantes-Villagrana AR; Rivas-Santiago B
    Invest Clin; 2012 Mar; 53(1):71-83. PubMed ID: 22524110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [HIV infection. Virus resistance: development and prevention].
    Link R; Miller V; Fätkenheuer G; Manegold C; Harrer T
    Med Monatsschr Pharm; 1999 Mar; 22(3):86-8. PubMed ID: 10223868
    [No Abstract]   [Full Text] [Related]  

  • 3. HIV chemotherapy.
    Richman DD
    Nature; 2001 Apr; 410(6831):995-1001. PubMed ID: 11309630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathogenesis of HIV infection as the key to eradication? New therapeutic approaches].
    Manegold C
    MMW Fortschr Med; 2000 Mar; 142 Suppl 1():34-9. PubMed ID: 10863308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [German-Austrian guidelines for antiretroviral therapy of HIV infection. (July, 2002, update)].
    Brockmeyer NH; ;
    Dtsch Med Wochenschr; 2003 May; 128 Suppl 1():S7-18. PubMed ID: 12736863
    [No Abstract]   [Full Text] [Related]  

  • 6. Potential Uses of Venom Proteins in Treatment of HIV.
    Uzair B; Bushra R; Khan BA; Zareen S; Fasim F
    Protein Pept Lett; 2018; 25(7):619-625. PubMed ID: 29956606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial peptides from marine invertebrates: challenges and perspectives in marine antimicrobial peptide discovery.
    Sperstad SV; Haug T; Blencke HM; Styrvold OB; Li C; Stensvåg K
    Biotechnol Adv; 2011; 29(5):519-30. PubMed ID: 21683779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV resistance and the developing world.
    Gupta RK; Pillay D
    Int J Antimicrob Agents; 2007 May; 29(5):510-7. PubMed ID: 17346940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy in the management of HIV infection.
    Vella S; Franca Pirillo M
    Methods Find Exp Clin Pharmacol; 1996; 18 Suppl C():23-6. PubMed ID: 9003571
    [No Abstract]   [Full Text] [Related]  

  • 10. Saquinavir in the management of HIV infection.
    Moyle G
    Br J Hosp Med; 1997 Jun 4-17; 57(11):560-4. PubMed ID: 9307673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Campaign against a chameleon. Therapeutic strategies to control a survival artist].
    MMW Fortschr Med; 2000 Mar; 142 Suppl 1():80-1. PubMed ID: 10863320
    [No Abstract]   [Full Text] [Related]  

  • 13. Minidefensins and other antimicrobial peptides: candidate anti-HIV microbicides.
    Cole AM
    Expert Opin Ther Targets; 2003 Jun; 7(3):329-41. PubMed ID: 12783570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacoresistance: an emerging clinical problem.
    Carosi G
    J Biol Regul Homeost Agents; 1998; 12(1-2 Suppl):9-14. PubMed ID: 9689572
    [No Abstract]   [Full Text] [Related]  

  • 15. Antimicrobial peptides in the interactions between insects and flagellate parasites.
    Boulanger N; Bulet P; Lowenberger C
    Trends Parasitol; 2006 Jun; 22(6):262-8. PubMed ID: 16635587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why HIV drug resistance matters: an overview.
    Learned J
    Posit Aware; 2005; 16(5):26-30. PubMed ID: 16220604
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemotherapy of human immunodeficiency virus (HIV) infection based on chemotherapeutic intervention with early steps of the virus replicative cycle.
    De Clercq E
    Postepy Biochem; 1995; 41(5 Suppl):338-42. PubMed ID: 8797234
    [No Abstract]   [Full Text] [Related]  

  • 18. Genotypic resistance tests for the clinical management of patients with primary HIV infection.
    Narciso P; Lazzarin A
    Scand J Infect Dis Suppl; 2003; 106():66-70. PubMed ID: 15000588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial peptides for leishmaniasis.
    Cobb SL; Denny PW
    Curr Opin Investig Drugs; 2010 Aug; 11(8):868-75. PubMed ID: 20721829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV suppression and risk of drug resistance mutations.
    Phillips AN; Loveday C; Johnson MA
    AIDS; 1998 Oct; 12(14):1930. PubMed ID: 9792396
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.